Joel Lewis
2022
In 2022, Joel Lewis earned a total compensation of $974.2K as Chief Executive Officer & President at Galectin Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $262,500 |
|---|---|
| Option Awards | $103,517 |
| Salary | $522,917 |
| Other | $85,247 |
| Total | $974,181 |
Lewis received $522.9K in salary, accounting for 54% of the total pay in 2022.
Lewis also received $262.5K in bonus, $103.5K in option awards and $85.2K in other compensation.
Rankings
In 2022, Joel Lewis' compensation ranked 3,087th out of 5,760 executives tracked by ExecPay. In other words, Lewis earned more than 46.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,087 out of 5,760 | 46th |
Division Manufacturing | 1,735 out of 3,136 | 45th |
Major group Chemicals And Allied Products | 818 out of 1,422 | 43rd |
Industry group Drugs | 764 out of 1,323 | 42nd |
Industry Pharmaceutical Preparations | 554 out of 969 | 43rd |
Source: SEC filing on October 6, 2023.
Lewis' colleagues
We found two more compensation records of executives who worked with Joel Lewis at Galectin Therapeutics in 2022.